Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

A Headache for Cardiologists: Ischemia with Non-Obstructive Disease

Treating patients with functional stress test induced ischemia and non-obstructive coronary artery disease (INOCA) is complex and often frustrating. 

Isquemia con enfermedad NO obstructiva.

The multifactorial nature of this disease in addition to the complex physiopathological relationship between angina and ischemia turn these patients into a real headache for cardiologists.

The CIAO-ISCHEMIA was recently published in Circulation and was designed to describe the natural history of symptoms and ischemia in patients with INOCA.

Patients included in this study are peculiar because they had been excluded from ISCHEMIA randomization for failing to meet the criteria for obstructive coronary artery disease.

They all presented angina and stress-induced wall motion abnormalities. The echocardiographic core laboratory was blinded to symptoms, coronary and the presence of coronary artery disease (CAD). 

The pharmacological treatment was left to physician criteria. Primary end point was the correlation between changes in angina frequency and changes in stress echocardiogram. Predictors were analyzed at one year after changes in symptoms and ischemia. These patients were also compared against those included in the ISCHEMIA trial (the only difference being the presence of obstructive CAD).


Read also: Post COVID-19 Persistent Symptoms: Far More Common than Expected.


Patients with INOCA included in the CIAO were far more often women (66% vs 26%) vs ISCHEMIA patients with obstructive CAD (p<0.001). Despite the latter, ischemia magnitude resulted similar between cohorts (median 4 ischemic segments).

Ischemia and angina symptoms were not correlated in CIAO or ISCHEMIA.

After one year, stress echocardiogram resulted normal in half the CIAO participants, while a quarter continued with severe to moderate stress induced ischemia (≥3 ischemic segments). Angina improved in nearly half of patients (43%) though not necessarily the same who saw improved ischemia. In fact, there was no correlation. 


Read also: AAS vs DAPT post TAVI: Meta-Analysis of Randomized Studies.


These are the inconsistencies between stress symptoms and signs that make INOCA patients so challenging when it comes to treating them.  

Conclusion

Treatment improved ischemia and angina in INOCA patients, even though there was no correlation between both. Stress induced ischemia amounts resulted similar between the CIAO cohort (with no obstructive lesions) and the ISCHEMIA cohort (with obstructive CAD). 

Original Title: Natural History of Patients with Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study.

Reference: Harmony R. Reynolds et al. Circulation. 2021 Jun 1. Online ahead of print. doi: 10.1161/CIRCULATIONAHA.120.046791. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...